How is the Rapport Therapeutics Inc. today?

The Rapport Therapeutics Inc. today is trading in the down by -2.82% at 8.27.

How has Rapport Therapeutics Inc. performed historically?

The Rapport Therapeutics Inc. is currently trading down -2.82% on an intraday basis in the past week the index fell -23.57%. The index has been down -17.55% in the past quarter and fell None% in the past year. You can view this in the overview section.

What is Rapport Therapeutics Inc. Annual Net Profit?

Rapport Therapeutics Inc. Annual Net Profit fell 125.11% in the last year to $78.31 M. Its sector's average net profit growth for the last fiscal year was -28.42%.

What is Rapport Therapeutics Inc. Price to Earning Ratio?

Rapport Therapeutics Inc. Price to Earning Ratio is -3.79, which is negative.

What is Rapport Therapeutics Inc. Stock Price?

Rapport Therapeutics Inc. Stock Price fell 23.57% underperformed its sector by 24.5% in the past week.

What is Rapport Therapeutics Inc. Quarterly Net profit?

Rapport Therapeutics Inc. Quarterly Net profit fell 6.15% YoY to $24.06 M. Its sector's average net profit growth YoY for the quarter was -80.7%.

What is Rapport Therapeutics Inc. Debt to Equity Ratio?

Rapport Therapeutics Inc. Debt to Equity Ratio is zero as the company is debt-free.

What is Rapport Therapeutics Inc. Return on Equity(ROE)?

Rapport Therapeutics Inc. Return on Equity(ROE) for the last financial year was -55.98%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Rapport Therapeutics Inc. Mutual Fund Holding?

Rapport Therapeutics Inc. Mutual Fund Holding increased by 2.81% in the last quarter to 39.58.

What is Rapport Therapeutics Inc. Institutional Holding?

Rapport Therapeutics Inc. Institutional Holding increased by 4.56% in the last quarter to 104.77.

Rapport Therapeutics Inc. XNAS: RAPP

Rapport Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Rapport Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Rapport Therapeutics Inc.
Rating: 0.44000
Author: Trendlyne DVM scores

about

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucid...

8.27 -0.24 (-2.82%)

72.19% Fall from 52W High

417.1K XNAS Volume

High volume today

XNAS 30 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Rapport Therapeutics Inc. is on 09 Jun 2025 for the purpose of Goldman Sachs 46th Annual Global Healthcare Conference 2025 See details

Not Eligible

Expensive Valuation

0.0 / 100

Technically Bearish

17.6 / 100

No estimates available

Rapport Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Rapport Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucid...

72.19% Fall from 52W High

High volume today

SWOT Analysis

Rapport Therapeutics Inc. Live Price Chart

Rapport Therapeutics Inc. FAQ

How is Rapport Therapeutics Inc. today?

Rapport Therapeutics Inc. today is trading in the red, and is down by -2.82% at 8.27.

How has Rapport Therapeutics Inc. performed historically?

Rapport Therapeutics Inc. is currently trading down -2.82% on an intraday basis. In the past week the stock fell -23.57%. stock has been down -17.55% in the past quarter and fell None% in the past year. You can view this in the overview section.